ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2017 American Transplant Congress

    Novel Biomarkers for Segregating Lung Transplant Rejection Phenotypes.

    J. Yang,1 B. Vanaudenaerde,2 T. Sigdel,1 J. Liberto,1 S. Verlden,2 M. Sarwal.1

    1Department of Surgery, University of California, San Francisco, San Francisco, CA; 2Department of Pneumology, University of Leuven, Leuven, Flemish Brabant, Belgium

    We sought to investigate biomarkers in BAL fluid and tissue for segregating BOS and RAS chronic rejection phenotypes in lung allografts. We had previously identified…
  • 2017 American Transplant Congress

    Integrated Magnetic-Electrochemical Exosome (iMEX) Technology to Detect Rejection in Kidney Transplant Recipients.

    J. Assaker, J. Park, S. Routray, S. Eskandari, H. Lee, J. Azzi.

    Transplantation Research Center, Harvard Medical School, Boston; Exosome Diagnostic Inc, Cambridge

    Methods for monitoring clinical rejection including increases in serum creatinine and urinary protein excretion may not reflect subclinical rejection. Similarly repeat biopsy may result in…
  • 2017 American Transplant Congress

    Liver Transplantation Outcomes Using Anti-Thymocyte Globulin Induction in Patients with Autoimmune Hepatitis.

    S. LeCorchick, A. Sharma, I. Yakubu, C. Bhati, T. Reichman, L. Kang, M. Levy.

    Transplantation Surgery, Virginia Commonwealth University, Richmond, VA

    Background: The use of rabbit anti-thymocyte globulin (ATG) induction in high immunological risk patients with autoimmune hepatitis (AIH) could lower the rejection rates after liver…
  • 2017 American Transplant Congress

    Extended Experience with Tocilizumab (Anti-IL6R) for Difficult to Desensitize (Des) Patients Awaiting HLA Incompatible Kidney Transplant.

    A. Vo, J. Choi, I. Kim, E. Huang, S. Louie, A. Kang, S. Williamson, K. Myers, A. Peng, R. Najjar, S. Jordan.

    Kidney Transplant, Cedars-Sinai Medical Center, LA, CA

    INTRODUCTION: ~30% of HS patients fail to respond to DES with IVIG+rituximab. IL6/IL-6R signaling is critical for B-cell differentiation to plasmablasts and IgG production. Tocilizumab…
  • 2017 American Transplant Congress

    Clinical Correlation of Endomyocardial Biopsies Molecular Profiling: Taking Rejection Diagnosis Beyond Histology.

    L. Potena,1 L. Borgese,1 A. Gaudenzi,1 V. Agostini,1 J. Reeve,2 M. Masetti,1 F. Grigioni,1 O. Leone,1 P. Halloran.

    1University of Bologna, Bologna, Italy; 2Alberta Transplant Applied Genomics Centre, Edmonton, Canada

    Histology grading of endomyocardial biopsies (EMB), the standard for diagnosing T-cell-mediated (TCMR) and antibody-mediated (ABMR) rejection, has serious issues with reproducibility (Transplantation 94 (11):1172177, 2012)…
  • 2017 American Transplant Congress

    Immunodominant Donor Specific Antibody Reduction with Proteasome Inhibitor Based Treatment: Clinical Variability and Implications for Long Term Graft Survival.

    A. Lichvar,1 A. Leino,1 S. Tremblay,1 A. Shields,2 B. Abu Jawdeh,1 B. Hardy,1 M. Anand,1 M. Cuffy,1 M. Cardi,1 R. Alloway,1 E. Woodle.1

    1University of Cincinnati, Cincinnati; 2The Christ Hospital, Cincinnati

    Proteasome inhibitor (PI) based regimens treat antibody mediated rejection (AMR) at least in part by eliminating donor specific antibody (DSA). iDSA response to PI-based therapy…
  • 2017 American Transplant Congress

    Pre-Transplant HLA-Specific B Cell Breadth of Reactivity in a Novel Multiplex Bead-Based Assay Predicts Rejection in Kidney Transplant Recipients.

    Z. Ilyas,1 A. Aki,1 A. Tambur,1 P. Heeger,2 M. Ansari.1

    1Northwestern University, Chicago; 2Icahn School of Medicine at Mount Sinai, New York

    Introduction: Recipients with broad sensitization to HLA defined by a high percentage of Panel Reactive Antibodies (PRA) are at higher immunologic risk for poor graft…
  • 2017 American Transplant Congress

    Regulatory T Cells Inhibit Plasmablast Formation and IgG Production by Tempering T Follicular Helper Cell Function.

    P. Fadakar, C. Macedo, M. Yamada, K. Hadi, D. Metes.

    Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA

    Background: Donor-specific antibodies (DSA) are an important biomarker for acute rejection, transplant glomerulopathy and late allograft failure in kidney transplantation. Few studies have characterized the…
  • 2017 American Transplant Congress

    Quantitative Gene Expression Analysis of CRM-Panel Genes Using FFPE Kidney Tissues for Transplant Injuries.

    T. Sigdel, M. Nguyen, D. Dobi, S.-C. Hsieh, J. Liberto, F. Vincenti, M. Sarwal, Z. Laszik.

    University of California San Francisco, San Francisco

    Background: A common immune response module (CRM) of 11 genes was identified to define acute rejection (AR) through meta-analyses of 1030 different engrafted tissues including…
  • 2017 American Transplant Congress

    Mitochondrial Permeability Can Regulate Endothelial Cell Necroptosis and Promote Cardiac Allograft Rejection.

    I. Gan,1,2 J. Jiang,1 D. Lian,1 A. Jevnikar,1,3 Z.-X. Zhang.1,2

    1Matthew Mailing Centre for Translational Transplant Studies, Western University, London, ON, Canada; 2Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada; 3Department of Medicine, Western University, London, ON, Canada

    Background: Transplant injury is invariably associated with programmed cell death (PCD) resulting in organ rejection. Many forms of PCD have been described including apoptosis, pyroptosis,…
  • « Previous Page
  • 1
  • …
  • 117
  • 118
  • 119
  • 120
  • 121
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences